T1	Condition 238 255	diabetes mellitus
T2	Condition-Name 238 255	diabetes mellitus
E1	Condition:T1 Name:T2
T3	Condition 47 70	post herpetic neuralgia
T4	Condition-Name 47 70	post herpetic neuralgia
E3	Condition:T3 Name:T4
T5	Condition 198 212	polyneuropathy
T6	Condition-Name 198 212	polyneuropathy
E5	Condition:T5 Name:T6
T7	Condition 361 369	diabetes
T8	Condition-Name 361 369	diabetes
E7	Condition:T7 Name:T8 Stability:T51 Duration:E26
T9	Condition 134 152	herpes zoster rash
T10	Condition-Name 134 152	herpes zoster rash
E9	Condition:T9 Name:T10 Temporality:E10
T13	Condition 1262 1265	PHN
T14	Condition-Name 1262 1265	PHN
E13	Condition:T13 Name:T14
T15	Eq-Operator 486 487	≤
A1	Eq-Operator-Value T15 LTEQ
T16	Eq-Temporal-Unit 108 114	months
A2	Eq-Temporal-Unit-Value T16 month
T17	Eq-Temporal-Unit 340 346	months
A3	Eq-Temporal-Unit-Value T17 month
T18	Eq-Temporal-Unit 399 405	months
A4	Eq-Temporal-Unit-Value T18 month
T19	Eq-Temporal-Unit 572 578	months
A5	Eq-Temporal-Unit-Value T19 month
T20	Eq-Unit 496 500	mmol
T21	Eq-Value 106 107	3
T22	Eq-Value 338 339	3
T23	Eq-Value 397 398	3
T24	Eq-Value 488 490	11
T25	Eq-Value 570 571	3
T26	Eq-Value 1023 1024	4
T27	Eq-Value 1042 1043	8
T28	Eq-Comparison 486 491	≤ 11%
E14	Eq-Comparison:T28 Operator:T15 Value:T24 Unit:T60
T29	Condition 77 81	pain
E2	Condition:T29 Name:T30 Duration:E6
T30	Condition-Name 77 81	pain
T31	And 72 76	with
E4	And:T31 Arg:E3 Arg2:E2
T32	Eq-Comparison 97 114	at least 3 months
E6	Eq-Comparison:T32 Operator:T33 Value:T21 Temporal-Unit:T16
T33	Eq-Operator 97 105	at least
A6	Eq-Operator-Value T33 GTEQ
T34	Temporal-Connection 115 120	after
E8	Temporal-Connection:T34 Arg:E6 Arg2:E10
A7	Temporal-Connection-Type-Value E8 after
T35	Eq-Comparison 125 130	onset
E10	Eq-Comparison:T35 Temporal-Recency:T36
T36	Eq-Temporal-Recency 125 130	onset
A8	Eq-Temporal-Recency-Value T36 first-time
T37	Modifier 183 197	distal painful
E12	Modifier:T37 Modifies:T6
T38	Or 153 155	OR
E15	Or:T38 Arg:E9 Arg2:E5
T39	Modifier 230 237	Type II
E16	Modifier:T39 Modifies:T2
T40	Modifier 220 226	Type I
E17	Modifier:T40 Modifies:T2
T41	Or 227 229	or
E18	Or:T41 Arg:E17 Arg2:E16
R1	Caused-By Arg1:E5 Arg2:E1	
T42	Condition 295 299	pain
E19	Condition:T42 Name:T43 Duration:E24
T43	Condition-Name 295 299	pain
T44	Modifier 285 294	bilateral
E20	Modifier:T44 Modifies:T43
T45	Modifier 272 283	symmetrical
E21	Modifier:T45 Modifies:T43
T46	And 256 260	with
E22	And:T46 Arg:E1 Arg2:E19
T47	Modifier 307 324	lower extremities
E23	Modifier:T47 Modifies:T43
T48	Eq-Comparison 329 346	at least 3 months
E24	Eq-Comparison:T48 Operator:T49 Value:T22 Temporal-Unit:T17
T49	Eq-Operator 329 337	at least
A9	Eq-Operator-Value T49 GTEQ
T50	And 347 350	and
E25	And:T50 Arg:E19 Arg2:E7
T51	Stability 370 383	under control
A10	Stability-Value T51 stable
T52	Eq-Comparison 388 405	at least 3 months
E26	Eq-Comparison:T52 Operator:T53 Value:T23 Temporal-Unit:T18
T53	Eq-Operator 388 396	at least
A11	Eq-Operator-Value T53 GTEQ
T54	Study 415 428	randomisation
E27	Study:T54 
T55	Temporal-Connection 406 414	prior to
E28	Temporal-Connection:T55 Arg:E26 Arg2:E27
A12	Temporal-Connection-Type-Value E28 before
T56	Observation 448 474	glycated haemoglobin level
E29	Observation:T56 Name:T57
T57	Observation-Name 448 474	glycated haemoglobin level
A13	Observation-Type-Value T57 lab
T58	Observation 476 481	HbA1c
E30	Observation:T58 Name:T59 Eq-Comparison:E14
T59	Observation-Name 476 481	HbA1c
A14	Observation-Type-Value T59 lab
R2	Abbrev-Of Arg1:E30 Arg2:E29	
T60	Eq-Unit 490 491	%
T61	Eq-Comparison 493 504	97 mmol/mol
E31	Eq-Comparison:T61 Value:T62 Unit:T20 Per:T63
T62	Eq-Value 493 495	97
T63	Eq-Unit 501 504	mol
R3	Equivalent-To Arg1:E31 Arg2:E14	
R4	Equivalent-To Arg1:E29 Arg2:E7	
T64	Stability 515 521	stable
A15	Stability-Value T64 stable
T65	Drug 530 537	insulin
E32	Drug:T65 Name:T66 Stability:T64
T66	Drug-Name 530 537	insulin
T67	And 506 509	and
E33	And:T67 Arg:E30 Arg2:E32
T68	Drug 555 565	medication
E34	Drug:T68 Duration:E38
T69	Condition 546 554	diabetic
E35	Condition:T69 Name:T70
T70	Condition-Name 546 554	diabetic
T71	Modifier 541 545	oral
E36	Modifier:T71 Modifies:E34
R5	Treatment-For Arg1:E34 Arg2:E35	
T72	Or 538 540	or
E37	Or:T72 Arg:E32 Arg2:E34
T73	Eq-Comparison 570 578	3 months
E38	Eq-Comparison:T73 Value:T25 Temporal-Unit:T19
T74	Study 588 597	screening
E39	Study:T74 
T75	Temporal-Connection 579 587	prior to
E40	Temporal-Connection:T75 Arg:E38 Arg2:E39
A16	Temporal-Connection-Type-Value E40 before
T76	And 599 602	and
E41	And:T76 Arg:E39
T77	Condition 626 634	diabetic
E42	Condition:T77 Name:T78
T78	Condition-Name 626 634	diabetic
T79	Drug 635 645	medication
E43	Drug:T79 Stability:T80 Temporality:E45
R6	Treatment-For Arg1:E43 Arg2:E42	
T80	Stability 616 622	change
A17	Stability-Value T80 change
T81	Negation 613 615	no
E44	Negation:T81 Negates:T80
T82	Eq-Comparison 646 653	planned
E45	Eq-Comparison:T82 Temporal-Period:T83
T83	Eq-Temporal-Period 646 653	planned
A18	Eq-Temporal-Period-Value T83 future
T84	Study 678 683	study
E46	Study:T84 
T85	Temporal-Connection 654 670	for the duration
E47	Temporal-Connection:T85 Arg:E45 Arg2:E46
A19	Temporal-Connection-Type-Value E47 during
T86	Condition 698 714	sensory symptoms
E48	Condition:T86 Name:T87 Polarity:T88
T87	Condition-Name 698 714	sensory symptoms
T88	Polarity 689 697	Positive
A20	Polarity-Value T88 positive
T89	Modifier 716 726	mechanical
E49	Modifier:T89 Modifies:T87
T90	Modifier 730 737	thermal
E50	Modifier:T90 Modifies:T87
T91	Or 727 729	or
E51	Or:T91 Arg:E49 Arg2:E50
T92	Modifier 755 766	neuropathic
E52	Modifier:T92 Modifies:T94
T93	Condition 767 771	pain
E53	Condition:T93 Name:T94
T94	Condition-Name 767 771	pain
R7	Caused-By Arg1:E48 Arg2:E53	
T95	Observation 797 821	painDETECT questionnaire
E54	Observation:T95 Name:T96
T96	Observation-Name 797 821	painDETECT questionnaire
A21	Observation-Type-Value T96 survey-or-questionnaire
T97	Observation 823 827	PD-Q
E55	Observation:T97 Name:T98
T98	Observation-Name 823 827	PD-Q
R8	Abbrev-Of Arg1:E55 Arg2:E54	
R9	Found-By Arg1:E53 Arg2:E54	
T99	Procedure 852 862	assessment
E56	Procedure:T99 Name:T100
T100	Procedure-Name 852 862	assessment
T101	Condition 893 897	pain
E57	Condition:T101 Name:T102
T102	Condition-Name 893 897	pain
T103	Modifier 881 892	neuropathic
E58	Modifier:T103 Modifies:T102
T104	Assertion 872 880	signs of
E59	Assertion:T104 Asserted:E57
A22	Assertion-Type-Value E59 possible
R10	Found-By Arg1:E57 Arg2:E56	
T105	And 829 832	and
E60	And:T105 Arg:E55 Arg2:E56
T11	Condition 922 925	PHN
E11	Condition:T11 Name:T138
T109	Observation 988 998	pain score
E65	Observation:T109 Name:T110 Temporality:E66
T110	Observation-Name 988 998	pain score
A23	Observation-Type-Value T110 measurement
T111	Eq-Comparison 982 987	daily
E66	Eq-Comparison:T111 Per:T112
T112	Eq-Temporal-Unit 982 987	daily
A24	Eq-Temporal-Unit-Value T112 day
T113	Observation 1006 1010	NPRS
E67	Observation:T113 Name:T114 Eq-Comparison:E68 Eq-Comparison2:E69
T114	Observation-Name 1006 1010	NPRS
T115	Eq-Comparison 1014 1024	at least 4
E68	Eq-Comparison:T115 Operator:T116 Value:T26
R13	Equivalent-To Arg1:E67 Arg2:E65	
T116	Eq-Operator 1014 1022	at least
A25	Eq-Operator-Value T116 GTEQ
T117	Eq-Comparison 1032 1043	more than 8
E69	Eq-Comparison:T117 Operator:T118 Value:T27
T118	Eq-Operator 1032 1041	more than
A26	Eq-Operator-Value T118 GT
T119	Negation 1029 1031	no
E70	Negation:T119 Negates:E69
T120	And 1025 1028	and
E71	And:T120 Arg:E68 Arg2:E70
T121	Study 1082 1095	randomisation
E72	Study:T121 
T122	Temporal-Connection 1075 1081	before
E73	Temporal-Connection:T122 Arg:E67 Arg2:E72
A27	Temporal-Connection-Type-Value E73 before
T123	Condition 1152 1156	pain
E74	Condition:T123 Name:T124 Severity:T127
T124	Condition-Name 1152 1156	pain
T125	Eq-Comparison 1133 1151	moderate to severe
E75	Eq-Comparison:T125 Value:T126 Value2:T127 Operator:T128
T126	Severity 1133 1141	moderate
A28	Severity-Value T126 moderate
T127	Severity 1145 1151	severe
A29	Severity-Value T127 severe
T128	Eq-Operator 1142 1144	to
A30	Eq-Operator-Value T128 BETWEEN
T129	Condition 1168 1174	causes
E76	Condition:T129 
T130	Other 1162 1167	other
E77	Other:T130 Is-Other:E76
R14	Caused-By Arg1:E74 Arg2:E76	
T131	Study 1193 1203	assessment
E78	Study:T131 Stability:T132
T132	Stability 1184 1192	confound
A31	Stability-Value T132 change
T133	Assertion 1180 1183	may
E79	Assertion:T133 Asserted:T132
A32	Assertion-Type-Value E79 hypothetical
R15	Caused-By Arg1:T132 Arg2:E76	
T134	Condition 1254 1257	DPN
E80	Condition:T134 Name:T135
T135	Condition-Name 1254 1257	DPN
T136	And 1258 1261	and
E81	And:T136 Arg:E80 Arg2:E13
T12	Condition 937 961	symmetrical distribution
E61	Condition:T12 Name:T106
T106	Condition-Name 937 961	symmetrical distribution
T107	Modifier 930 936	distal
E62	Modifier:T107 Modifies:T106
T108	Modifier 910 920	dermatomal
E63	Modifier:T108 
T137	Or 927 929	or
E64	Or:T137 Arg:E63 Arg2:E62
T138	Condition-Name 922 925	PHN
R11	Abbrev-Of Arg1:E11 Arg2:E63	
T139	Condition 963 966	DPN
E82	Condition:T139 Name:T140
T140	Condition-Name 963 966	DPN
R12	Abbrev-Of Arg1:E82 Arg2:E61	
T141	And 898 900	in
E83	And:T141 Arg:E57 Arg2:E61
